Cargando…
The Three Pillars of COVID-19 Convalescent Plasma Therapy
The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread rapidly around the world in the last year causing the coronavirus disease 2019 (COVID-19), which still is a severe threat for public health. The therapeutic management of COVID-19 is challenging as, up until no...
Autores principales: | Franchini, Massimo, Liumbruno, Giancarlo Maria, Piacentini, Giorgio, Glingani, Claudia, Zaffanello, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073137/ https://www.ncbi.nlm.nih.gov/pubmed/33919577 http://dx.doi.org/10.3390/life11040354 |
Ejemplares similares
-
Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
por: Franchini, Massimo, et al.
Publicado: (2021) -
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022) -
Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini, Massimo, et al.
Publicado: (2021) -
Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review
por: Franchini, Massimo, et al.
Publicado: (2021) -
The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review
por: Zaffanello, Marco, et al.
Publicado: (2021)